ClariTrial | Search Clinical Trials

Status

Phase

141,158 results for “Cancer”

Page 1 of 9411

Active

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Phase 1Myelodysplastic Syndromes (MDS)

AzacitidineVenetoclax

AbbVie129 participants37 sites · United States, Australia, CanadaCompletes Jan 2027

Compare CT.gov Full analysis →

Completed

Results posted

Little Cigar and Cigarillo Warnings for Youth

N/ALittle Cigars and Cigarillos (LCC) Use

FDA warnings + ImageFDA Warnings Text-OnlySurgeon General Text-Only Warnings

UNC Lineberger Comprehensive Cancer Center928 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

Phase 2Breast Cancer

Indocyanine greenRadioisotope

National Cancer Center, Korea130 participants1 site · South KoreaCompletes Mar 2018

Compare CT.gov Full analysis →

Completed

Results posted

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Phase 2Hematologic Malignancies

Tildrakizumab

Medical College of Wisconsin51 participants1 site · United StatesCompletes Jun 2024

Compare CT.gov Full analysis →

Completed

Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 2Multiple Myeloma in RelapseMultiple Myeloma, Refractory

PomalidomideCyclophosphamideDexamethasone

Ajai Chari35 participants1 site · United StatesCompletes May 2019

Compare CT.gov Full analysis →

Completed

Results posted

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

Phase 2Neuroendocrine Carcinoma

AvastinRAD001

M.D. Anderson Cancer Center41 participants1 site · United StatesCompletes Oct 2011

Compare CT.gov Full analysis →

Recruiting

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Phase 2Locally Advanced Rectal Cancer (LARC)

ExperimentalControl

First Affiliated Hospital of Zhejiang University116 participants1 site · ChinaCompletes Dec 2029

Compare CT.gov Full analysis →

Completed

Results posted

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Phase 1Phase 2Leukemia

VosaroxinDecitabine

M.D. Anderson Cancer Center66 participants1 site · United StatesCompletes Jan 2021

Compare CT.gov Full analysis →

Completed

Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

N/ALung CancerColorectal CancerHead and Neck Cancer

University of Kansas Medical Center70 participants1 site · United StatesCompletes Sep 2008

Compare CT.gov Full analysis →

Not Yet Recruiting

Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Phase 1Phase 2Unresectable Hepatocellular CarcinomaPembrolizumabLenvatinib

Lenvatinib/Pembrolizumab plus SBRT combinations

National Taiwan University Hospital27 participants1 site · TaiwanCompletes Sep 2026

Compare CT.gov Full analysis →

Completed

Self-acupressure and Zhan Zhuang for Symptom Cluster Management

N/ABreast Cancer FemaleSurvivorship

zhan-zhuangself-acupressure

The Hong Kong Polytechnic University50 participants1 site · ChinaCompletes Sep 2024

Compare CT.gov Full analysis →

Completed

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase 1Solid Tumors

ZIO-101

M.D. Anderson Cancer Center47 participants1 site · United StatesCompletes Apr 2008

Compare CT.gov Full analysis →

Active

Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

N/ADiffuse Large B Cell Lymphoma

CAR-T cells monitoring

Centre Henri Becquerel40 participants1 site · FranceCompletes Sep 2025

Compare CT.gov Full analysis →

UNKNOWN

Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease

N/AErdheim-Chester Disease

Groupe Hospitalier Pitie-Salpetriere20 participants2 sites · United States, FranceCompletes Dec 2016

Compare CT.gov Full analysis →

Recruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

N/ABreast CancerChemotherapySentinel Lymph Node

Axillary RadiotherapyLymphadenectomy

Hospital Universitari de Bellvitge820 participants60 sites · Australia, SpainCompletes Jun 2026

Compare CT.gov Full analysis →

1–15 of 141,158

Explore/Cancer

Status

Phase

141,158 results for “Cancer”

Page 1 of 9411

Active

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Phase 1Myelodysplastic Syndromes (MDS)

AzacitidineVenetoclax

AbbVie129 participants37 sites · United States, Australia, CanadaCompletes Jan 2027

Compare CT.gov Full analysis →

Completed

Results posted

Little Cigar and Cigarillo Warnings for Youth

N/ALittle Cigars and Cigarillos (LCC) Use

FDA warnings + ImageFDA Warnings Text-OnlySurgeon General Text-Only Warnings

UNC Lineberger Comprehensive Cancer Center928 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

Phase 2Breast Cancer

Indocyanine greenRadioisotope

National Cancer Center, Korea130 participants1 site · South KoreaCompletes Mar 2018

Compare CT.gov Full analysis →

Completed

Results posted

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Phase 2Hematologic Malignancies

Tildrakizumab

Medical College of Wisconsin51 participants1 site · United StatesCompletes Jun 2024

Compare CT.gov Full analysis →

Completed

Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 2Multiple Myeloma in RelapseMultiple Myeloma, Refractory

PomalidomideCyclophosphamideDexamethasone

Ajai Chari35 participants1 site · United StatesCompletes May 2019

Compare CT.gov Full analysis →

Completed

Results posted

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

Phase 2Neuroendocrine Carcinoma

AvastinRAD001

M.D. Anderson Cancer Center41 participants1 site · United StatesCompletes Oct 2011

Compare CT.gov Full analysis →

Recruiting

SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Phase 2Locally Advanced Rectal Cancer (LARC)

ExperimentalControl

First Affiliated Hospital of Zhejiang University116 participants1 site · ChinaCompletes Dec 2029

Compare CT.gov Full analysis →

Completed

Results posted

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Phase 1Phase 2Leukemia

VosaroxinDecitabine

M.D. Anderson Cancer Center66 participants1 site · United StatesCompletes Jan 2021

Compare CT.gov Full analysis →

Completed

Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

N/ALung CancerColorectal CancerHead and Neck Cancer

University of Kansas Medical Center70 participants1 site · United StatesCompletes Sep 2008

Compare CT.gov Full analysis →

Not Yet Recruiting

Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.

Phase 1Phase 2Unresectable Hepatocellular CarcinomaPembrolizumabLenvatinib

Lenvatinib/Pembrolizumab plus SBRT combinations

National Taiwan University Hospital27 participants1 site · TaiwanCompletes Sep 2026

Compare CT.gov Full analysis →

Completed

Self-acupressure and Zhan Zhuang for Symptom Cluster Management

N/ABreast Cancer FemaleSurvivorship

zhan-zhuangself-acupressure

The Hong Kong Polytechnic University50 participants1 site · ChinaCompletes Sep 2024

Compare CT.gov Full analysis →

Completed

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase 1Solid Tumors

ZIO-101

M.D. Anderson Cancer Center47 participants1 site · United StatesCompletes Apr 2008

Compare CT.gov Full analysis →

Active

Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

N/ADiffuse Large B Cell Lymphoma

CAR-T cells monitoring

Centre Henri Becquerel40 participants1 site · FranceCompletes Sep 2025

Compare CT.gov Full analysis →

UNKNOWN

Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease

N/AErdheim-Chester Disease

Groupe Hospitalier Pitie-Salpetriere20 participants2 sites · United States, FranceCompletes Dec 2016

Compare CT.gov Full analysis →

Recruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

N/ABreast CancerChemotherapySentinel Lymph Node

Axillary RadiotherapyLymphadenectomy

Hospital Universitari de Bellvitge820 participants60 sites · Australia, SpainCompletes Jun 2026

Compare CT.gov Full analysis →

1–15 of 141,158